Why Is Viking Therapeutics Stock (VKTX) Down 40% Today?
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viking Therapeutics noted that the study met its primary and secondary endpoints, with patients experiencing significant weight loss compared to placebo. This came in at a mean of up to 10.9%. Up to 80% of patients in the trial experienced weight loss of greater than 10%, compared with 5% for placebo. 20% of patients discontinued the study due to an adverse event, compared to 13% for placebo.
Brian Lian, Ph.D., CEO of Viking Therapeutics, said, 'The progressive nature of the weight loss curves suggests the potential for further improvement with longer dosing periods. The experimental maintenance arm of this study provides an encouraging signal that supports our belief that transitioning patients from higher doses, injectable or oral, to low oral doses represents a promising approach to weight maintenance therapy.'
Viking Therapeutics Stock Movement Today
While the VK2735 clinical trial met its primary endpoint, it doesn't appear to have impressed investors. Shares of VKTX stock were down 37.18% in pre-market trading on Tuesday, following a 5.15% loss yesterday. The shares have also increased 4.6% year-to-date, but fell 36.36% in the past 12 months.
Today's drop came with strong trading of Viking Therapeutics stock. More than 3.3 million shares were traded this morning, closing in on a three-month daily average of about 4.29 million shares.
Is Viking Therapeutics Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Viking Therapeutics is Strong Buy, based on 14 Buy and two Hold ratings over the past three months. With that comes an average VKTX stock price target of $88.71, representing a potential 110.76% upside for the shares.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
2 hours ago
- Time Business News
MK-677 and Its Role in Growth Hormone Studies
When researchers look at ways to study growth hormone and its effects, one compound often comes up in discussion: MK-677. Many people who work in labs or research settings look to purchase MK-677 from trusted sources such as PureRawz. This compound, also called Ibutamoren, has been studied for how it may support growth hormone release in the body. While it is not approved for medical use, it is valued in research because of its unique properties and how it works in controlled studies. MK-677, also known as Ibutamoren, is a compound that acts as a growth hormone secretagogue. That means it helps the body release more growth hormone naturally instead of directly replacing it. Scientists became interested in MK-677 because of its ability to increase both growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in research models. Growth hormone plays an important role in many functions of the body. It supports cell growth, muscle development, recovery, and metabolism. IGF-1 works closely with growth hormone to affect tissue growth and repair. This is why MK-677 has become a point of focus for researchers studying hormones, metabolism, and even aging. MK-677 works by mimicking the hormone ghrelin. Ghrelin is often called the 'hunger hormone,' but it also has a strong role in signaling the release of growth hormone from the pituitary gland. By binding to ghrelin receptors in the brain, MK-677 triggers the same pathways that lead to more growth hormone production. This method is interesting to researchers because it allows the body to keep its natural rhythm of hormone release. Instead of giving growth hormone directly, which can disrupt natural patterns, MK-677 helps maintain a more natural cycle. This makes it a useful compound in controlled growth hormone studies. Over the years, MK-677 has been included in many types of research. Some of the main areas where scientists have shown interest include: Growth hormone is linked to muscle repair and development. In studies, MK-677 has been observed to raise GH and IGF-1 levels, which are both connected to muscle growth. Researchers often look at how MK-677 might play a role in recovery after exercise, injury, or age-related muscle decline. As people age, bone density can decrease, leading to fractures and weakness. Growth hormone and IGF-1 are both important in keeping bones strong. Research has suggested that MK-677 may support bone health by stimulating hormone pathways that affect bone density. Growth hormone release happens most during sleep. Some studies have found that MK-677 may improve sleep quality, especially deep sleep, which is essential for recovery and brain function. Scientists are also curious about whether MK-677 may have an indirect effect on memory and learning through its connection with GH and IGF-1. Growth hormone plays a role in how the body uses fat and builds muscle. In research, MK-677 has been linked with changes in metabolism, including fat storage and energy use. This makes it interesting for studies on obesity, metabolic conditions, and related health concerns. Because growth hormone levels naturally decline with age, researchers have studied MK-677 to see if it could play a role in slowing down age-related changes. While results are still early, the potential link between MK-677, GH, and aging is an area of ongoing interest. When working with compounds like MK-677, quality and purity are very important. That is why researchers often rely on trusted sources such as PureRawz. With so many suppliers online, it can be hard to know which one provides tested and verified products. PureRawz is known for its focus on lab-tested compounds, which makes it a dependable option for researchers who want accurate results in their studies. Buying from a verified source is not just about trust—it also affects the outcome of research. If a compound is not pure, results may not be reliable. For this reason, those who want to purchase MK-677 for study purposes look for vendors like PureRawz that prioritize transparency and testing. It is important to remember that MK-677 is not approved for medical use. Its availability is for research purposes only. Scientists use it in labs to better understand growth hormone and related pathways. Anyone who purchases MK-677 should do so only for controlled research. The role of MK-677 in growth hormone studies continues to expand. While early research has shown promising results in areas like muscle health, sleep, and metabolism, more studies are needed to confirm long-term effects and safety. As interest grows in hormone-related research, MK-677 will likely remain a key compound for study. Whether the focus is aging, recovery, or hormone balance, its ability to stimulate growth hormone release makes it a unique tool for scientists. MK-677, or Ibutamoren, stands out as a research compound because of its effect on growth hormone and IGF-1 levels. By acting like ghrelin, it stimulates natural hormone release in a way that supports multiple areas of study, including muscle health, sleep, metabolism, and aging. For researchers looking to purchase MK-677, choosing a trusted source like PureRawz is essential to ensure quality and reliability. While MK-677 is not for medical use, its role in controlled studies continues to offer valuable insights into how growth hormone works in the body. TIME BUSINESS NEWS
Yahoo
4 hours ago
- Yahoo
Minnesota minimum wage will increase 2.5% to $11.41 per hour on Jan. 1
A server resets tables at a Minnesota restaurant earlier this year. (Photo by Ellen Schmidt/Minnesota Reformer) Minnesota's statewide minimum wage will increase 28 cents to $11.41 per hour on Jan. 1, a 2.5% increase based on the annual rate of inflation. The minimum wage applies to virtually all employees since the Democratic-controlled Legislature eliminated a lower minimum wage for small businesses, workers younger than 18 and workers on J-1 visas in 2024. (As before, tips cannot be counted toward the minimum wage.) Only workers under 20 years old in their first 90 days of training may receive a lower wage of $9.31 per hour starting in 2026. Minneapolis and St. Paul each have higher minimum wages of $15.97 per hour, which will increase with inflation in 2026. Small and micro businesses in St. Paul may pay a lower minimum wage, but the city is phasing in a single minimum wage for all employees by 2028. Minnesota's minimum wage is higher than most of its neighbors' (save South Dakota), but it isn't enough to cover basic living expenses. The cost of living for a childless, working-age adult requires earning $17.68 per hour, according to the state Department of Employment and Economic Development. A household with two children requires two parents earning at least $24.25 per hour. The federal minimum wage of $7.25 per hour has remained unchanged since 2009 and is the effective minimum wage in 20 states, including Wisconsin. Minnesota's minimum wage has been indexed to inflation since 2018 but was limited to annual adjustments of 2.5% until last year when lawmakers raised the threshold to 5% to ensure the lowest paid workers receive larger raises in periods of high inflation. The increase will directly affect a relatively small number of workers. Fewer than 90,000 salaried and hourly jobs out of more than 3.3 million in Minnesota were paid at or below the minimum wage in 2023, according to the state's latest minimum wage report. Still, a rising minimum wage puts upward pressure on jobs paying just above minimum wage, creating a ripple effect across a larger number of workers. Solve the daily Crossword
Yahoo
4 hours ago
- Yahoo
Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot.
It's late August, there's a hurricane coming up the East Coast, schools are starting to open, and no one has any idea who can get an updated Covid-19 shot. It has killed up to 56,000 people in the U.S. since last October, according to the Centers for Disease Control and Prevention, and sickened up to 18 million. Pfizer Moderna and Novavax all plan to launch new versions of their Covid-19 vaccines this fall, updated to target a family of Covid-19 viruses called JN.1.
